USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
imatinib basic information |
product name: | imatinib |
synonyms: | ima-3;imatinib;imatinib-d3;akos 91378;imatinib 99+%;benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate |
cas: | 152459-95-5 |
mf: | c29h31n7o |
mw: | 493.6 |
einecs: | |
product categories: | molecular targeted antineoplastic;pharmaceutical intermediate;imatinib;aromatics;heterocycles;impurities;intermediates & fine chemicals;pharmaceuticals;api;gleveec;antineoplastic;anti-cancer & immunity |
mol file: | 152459-95-5.mol |
imatinib chemical properties |
mp | 208-210°c (dec.) |
storage temp. | refrigerator |
cas database reference | 152459-95-5(cas database reference) |
safety information |
imatinib usage and synthesis |
chemical properties | orange solid |
usage | imatinib mesylate is orally bioavailability mesylate salt of imatinib, which is a multi-target inhibitor of v-abl, c-kit and pdgfr with ic50 of 0.6 μm, 0.1 μm and 0.1 μm, respectively. imatinib also known as gleevec, glivec, cgp-57148b, sti-571 & imatinib |
usage | antineoplastic |
usage | atypical antipsychotic |
usage | imatinib impurity. |
imatinib preparation products and raw materials |
imatinib basic information |
product name: | imatinib |
synonyms: | ima-3;imatinib;imatinib-d3;akos 91378;imatinib 99+%;benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate |
cas: | 152459-95-5 |
mf: | c29h31n7o |
mw: | 493.6 |
einecs: | |
product categories: | molecular targeted antineoplastic;pharmaceutical intermediate;imatinib;aromatics;heterocycles;impurities;intermediates & fine chemicals;pharmaceuticals;api;gleveec;antineoplastic;anti-cancer & immunity |
mol file: | 152459-95-5.mol |
imatinib chemical properties |
mp | 208-210°c (dec.) |
storage temp. | refrigerator |
cas database reference | 152459-95-5(cas database reference) |
safety information |
imatinib usage and synthesis |
chemical properties | orange solid |
usage | imatinib mesylate is orally bioavailability mesylate salt of imatinib, which is a multi-target inhibitor of v-abl, c-kit and pdgfr with ic50 of 0.6 μm, 0.1 μm and 0.1 μm, respectively. imatinib also known as gleevec, glivec, cgp-57148b, sti-571 & imatinib |
usage | antineoplastic |
usage | atypical antipsychotic |
usage | imatinib impurity. |